Dr. David Martin Addresses Biosimilars 2008 Conference in Washington D.C.

Date:  Mon, 2008-09-22

Dr. David Martin Addresses Biosimilars 2008 Conference in Washington D.C.

Charlottesville, VA − September 22, 2008 −−M·CAM’s Executive Chairman Dr. David Martin will join an international group of intellectual property experts in discussing the changing face of intellectual property in the fields of biotechnology and pharmaceutical development. In his presentation, Dr. Martin will focus on the changing economic conditions in the global pharmaceutical industry closely examining the sustainability of the “merchant bank” models that have been adopted by global dominant brands. With innovation pipelines at all time lows for many global players, new innovations and new business models will add significant volatility in both finance and IP policy.

Conference Details